If you’ve been told you have breast cancer, it’s important to ask your doctor and other healthcare providers questions so you thoroughly understand your diagnosis, treatment plan options, and what you can expect throughout treatment and recovery.
A team led by researchers at Baylor College of Medicine is coming closer to delivering on the promise of personalized breast cancer therapy with a strategy to predict the most likely response of a cancer to a specific less toxic treatment regimen.
Women should start getting regular mammograms at the age of 40, according to a new recommendation being drafted by the U.S. Preventive Services Task Force.
Cancer therapies associated with cardiotoxicity risk including anthracyclines and HER2-targeted agents remain important cornerstones of curative and life-prolonging breast cancer treatment.
Metastatic breast cancer has no cure and has proven stubbornly resistant to one of the most innovative and promising new cancer treatments: immunotherapy.
The FDA has approved Orserdu, a new oral medicine to treat metastatic, estrogen receptor-positive, HER2-negative breast cancer with an ESR1 mutation.
Breast cancer in men is a rare condition that affects men of all ages, though it is most commonly diagnosed in men over the age of 60.
Abnormal cells aren’t cancerous, but they may increase your risk of developing cancer....If abnormal cells move beyond the layer of tissue where they originated, the cells become invasive.
Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.
Breast cancer surgery has come a long way but experts and patients are now looking at addressing sensation loss as the next frontier.